R&D spending: $343,972,000
Percentage of revenues: 13.3%
2018 overall revenue ranking: 36BioMérieux (Marcy-I’Étoile, France) is a biotechnology company providing in vitro diagnostics. It develops systems reagents and software for private and hospital laboratories to diagnose infectious diseases. The systems can process blood, urine, stool, cerebrospinal fluid and saliva, among other things, to help clinicians make better-informed treatment decisions.
The company recently touted its Vitek MS MALDI-TOF1 mass spectrometry system. The system is designed for mycobacteria, Nocardia and molds.